Patent Assignment
Reel/Frame 071349/0825
Change of Name
Recorded: 2025-05-21
Pages: 4
Assignor
PARK THERAPEUTICS, INC.
Executed: 2025-02-13
Assignee
ADNEURIS THERAPEUTICS, INC.
2031 US HIGHWAY 130, MONMOUTH JUNCTION, NEW JERSEY, 08852
Covered Properties
(31)
Compositions Containing Spirocyclic Cyclohexane Compounds
Spirocyclic Cyclohexane Compounds
Spirocyclic Cyclohexane Compounds
Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds
Method for Synthesizing Substituted Aminocyclohexanone Compounds
Crystalline (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,B]Indol]-4-Amine
Solid forms of (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3' H-spiro-[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine hydrochloride
Solid Forms of (1 R,4R)-6' -Fluoro-(N, N-Dimethyl)-4-Phenyl-4' ,9'-Dihydro-3'H-Spiro[ Cyclohexane-1,1 '-Pyrano-[3,4,B]Indol]-4-Amine and Sulfuric Acid
Process for the Preparation of (1R,4R)-6'-Fluoro-(N,N-Dimethyl- and N-Methyl)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano-[3,4,B]Indol]-4-Amine
Crystalline (1r, 4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
Crystalline (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,B]Indol]-4-Amine and a Nsar
Pharmaceutical Composition Comprising (1r,4r)-6'-flouro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4'9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,B]Indol]-4-Amine and a Gabapentinoid
Pharmaceutical Dosage Forms Comprising 6'-Fluoro-(N-Methyl- or N,N-Dimethyl-)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,b]Indol]-4-Amine
Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds
Pharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano-[3,4,B]Indol]-4-Amine and a Propionic Acid Derivative
Pharmaceutical Dosage Forms Comprising 6'-Fluoro-(N-Methyl- or N,N-Dimethyl-)-4-Phenyl-4',9'-Dihydro-3'H-Spiro[Cyclohexane-1,1'-Pyrano[3,4,b]Indol]-4-Amine
Process for the Preparation of 5-Fluorotryptophol
Cebranopadol for Treating Pain in Subjects with Impaired Hepatic and/or Impaired Renal Function
Titration of Cebranopadol
Pharmaceutical Composition Comprising (1R,4R)-6'-Fluoro-N,N-Dimethyl-4-Phenyl-4',9'-Dihydro-3'H-Spiro [Cyclohexane-1,1'-Pyrano-[3,4,B]Indol]-4-Amine and Paracetamol or Propacetamol
Titration of Cebranopadol
Titration of Cebranopadol
Application:
18/933,387 →
Publication:
US 2025/0255849
Regimens and Compositions Useful for Alleviating Pain
Application:
63/387,086 →
Regimens and Compositions Useful for Alleviating Pain
Application:
63/485,139 →
Regimens and Compostions Useful for Alleviating Pain
Application:
63/578,894 →
Regimens and Compositions Useful for Alleviating Pain
Application:
63/679,443 →
Regimens and Compositions Useful for Alleviating Pain
Application:
63/680,406 →
Related Assignments
(14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 30, 2012
From: PRUEHS, STEFAN; GRIEBEL, CARSTEN; MUELLER, MARITA
To: GRUENENTHAL GMBH
Reel/Frame 027618/0001 →
Assignment of Assignor's Interest
Aug 2, 2012
From: GRUSS, MICHAEL; KLUGE, STEFAN; PRUEHS, STEFAN
To: GRUENENTHAL GMBH
Reel/Frame 028711/0237 →
Assignment of Assignor's Interest
Feb 8, 2013
From: GRUSS, MICHAEL; KLUGE, STEFAN; PRUEHS, STEFAN
To: GRUENENTHAL GMBH
Reel/Frame 029780/0796 →
Assignment of Assignor's Interest
Feb 8, 2013
From: KLUGE, STEFAN; GRUSS, MICHAEL; SIEBER, ANDREAS
To: GRUENENTHAL GMBH
Reel/Frame 029780/0577 →
Assignment of Assignor's Interest
Feb 8, 2013
From: PRUEHS, STEFAN; HELL, WOLFGANG; GRIEBEL, CARSTEN
To: GRUENENTHAL GMBH
Reel/Frame 029780/0820 →
Assignment of Assignor's Interest
Jul 24, 2013
From: FROSCH, STEFANIE; LINZ, KLAUS; SCHIENE, KLAUS
To: GRUENENTHAL GMBH
Reel/Frame 030863/0051 →
Assignment of Assignor's Interest
Aug 16, 2013
From: KLUGE, STEFAN; PRUEHS, STEFAN; GRUSS, MICHAEL
To: GRUENENTHAL GMBH
Reel/Frame 031029/0376 →
Assignment of Assignor's Interest
Sep 10, 2013
From: FROSCH, STEFANIE; LINZ, KLAUS; SCHIENE, KLAUS
To: GRUENENTHAL GMBH
Reel/Frame 031173/0698 →
Assignment of Assignor's Interest
Sep 11, 2013
From: CHRISTOPH, THOMAS; FROSCH, STEFANIE; LINZ, KLAUS
To: GRUENENTHAL GMBH
Reel/Frame 031182/0777 →
Assignment of Assignor's Interest
Sep 18, 2013
From: FROSCH, STEFANIE; LINZ, KLAUS; SCHIENE, KLAUS
To: GRUENENTHAL GMBH
Reel/Frame 031227/0592 →
Assignment of Assignor's Interest
Nov 1, 2016
From: PRUEHS, STEFAN; SCHAEFER, OLAF
To: GRUENENTHAL GMBH
Reel/Frame 040186/0435 →
Assignment of Assignor's Interest
Aug 18, 2021
From: GRÜNENTHAL GMBH
To: PARK THERAPEUTICS, INC.
Reel/Frame 057212/0157 →
Security Interest
Sep 26, 2024
From: TRIS PHARMA, INC.; PARK THERAPEUTICS, INC.
To: PROVIDENT BANK
Reel/Frame 069065/0576 →
Corrective Assignment to Correct the the Assignment Previously Recorded Previously Recorded at Reel: 068713 Frame: 0499. Assignor(S) Hereby Confirms the Assignment.
Oct 24, 2024
From: TRIS PHARMA, INC.; PARK THERAPEUTICS, INC.
To: PROVIDENT BANK
Reel/Frame 070760/0864 →